baber/WOPTO huggingface dataset:
Patent NZ-548450-A (NZ)
Title: Floor covering and locking system and an equipment for production of e.g floorboards
Inventor: PERVAN DARKO
IPC: B27M3/04
Filed: 2005-01-13
Abstract: A semi-floating floor comprising rectangular floorboards joined with a mechanical locking system, the joined floorboards of the locking system having a horizontal plane HP which is parallel to the floor surface and a vertical plane which is perpendicular to the horizontal plane HP, the locking system including mechanically cooperating locking means for vertical joining parallel to the vertical plane and for horizontal joining parallel to the horizontal plane HP of a first and a second joint edge, the vertical locking means comprising a tongue 10 which cooperates with a tongue groove 9 and the horizontal locking means comprising a locking element with a locking surface 14 which cooperates with a locking groove 15, the format, installation pattern and locking system of the floorboards being designed in such a manner that a floor surface of 1 * 1 meter can change in length in at least one direction at least 1 mm when the floorboards are subjected to a compressive or a tensile load in the horizontal plane and the change in length can occur without visible joint gaps, and wherein a surface layer of the floorboard is laminate or wood veneer, the core of the floorboard is a wood based board, the change in floor length is at least 1.0 mm when a force of 100 kg/m of the joint edge is used, the average joint gaps do not exceed 0.15 mm when the force is 100 kg/m of joint edge.
Patent NZ-548690-A (NZ)
Title: Coupling reactions useful in the preparation of (1H-tetrazol-5-yl)-biphenyl derivatives
Inventor: KRELL CHRISTOPH
IPC: C07D405/04
Filed: 2005-02-01
Abstract: The disclosure relates to a process for the manufacture of intermediates that may be used for the manufacture of angiotensin receptor blockers (ARBs), (also called angiotension II receptor antagonists or AT1 receptor antagonists) comprising as a common structural feature a (1H-tetrazol-5-yl)-biphenyl ring. ARBs can, for example, be used for the treatment of hypertension and related diseases and conditions. Particularly disclosed is a process for the preparation of a protected 2'-(1H-tetrazol-5-yl)-biphenyl-4-carbaldehyde of formula (I), wherein the variables shown in formula (I) are as defined in the specification.
Patent NZ-552480-A (NZ)
Title: Antibodies directed against amyloid-beta peptide and methods of using same
Inventor: ROSENTHAL ARNON
IPC: A61P25/00
Filed: 2005-08-01
Abstract: Provided is the use of an antibody that specifically binds to a beta-amyloid peptide or an aggregated form of a beta-amyloid peptide, wherein the antibody comprises at least one CDR region selected from the group consisting of a specified amino acid sequence of heavy or light chain CDR1, CDR2 or CDR3 region for the manufacture of a medicament for the treatment of a disease characterized by aberrant deposition of beta-amyloid in a subject. Further provided are variants of the antibodies, polynucleotides encoding the antibodies and methods of making the antibodies.
Patent NZ-561409-A (NZ)
Title: Metabolically engineered cells for the production of resveratrol or an oligomeric or glycosidically-bound derivative thereof
Inventor: KATZ MICHAEL
IPC: C12N9/02
Filed: 2006-02-21
Abstract: Disclosed is an isolated or recombinant micro-organism which produces resveratrol. The disclosed microorganism has an operative metabolic pathway producing 4-coumaric acid and producing resveratrol there from, or an oligomeric or glycosidically-bound derivative thereof. The 4-coumaric acid is produced from L-phenylalanine by the action of an L-phenylalanine ammonia lyase and a cinnamate 4-hydroxylase expressed in said micro-organism or from tyrosine by the action of an L-phenylalanine ammonia lyase or of a tyrosine ammonia lyase expressed in said micro-organism. The 4-coumaroyI-CoA is formed from said coumaric acid in a reaction catalysed by a 4-coumarate-CoA ligase expressed in said micro-organism, and resveratrol or a said oligomeric or gIycosidically-bound derivative thereof is produced from said 4-coumaroyl-CoA in a reaction catalysed by a resveratrol synthase expressed in said micro-organism.
Patent NZ-562131-A (NZ)
Title: Server and method for computer communication for automatically performing and administrating a comparison
Inventor: LIALIAMOU ELENI
IPC: A63F13/12
Filed: 2006-04-13
Abstract: A communication server for automatically performing and administrating a comparison, its result and data correlated to the result is disclosed. The server is connectable to a network and accessible via the network by at least two users via a mobile phone. The server comprises a platform program accessible by the users and configured to request availability of first data correlated to money from the users and programmed to allow communication between the users in real time interactively; a correlation program accessible by the users and configured to allow the users to correlate first data correlated to money to the result of a comparison of second data. The comparison of the second data is comparing the course or outcome of an entertainment computer game, which is produced by steering signals from an input unit as being the second data entered by the users simultaneously in order to perform a competition. The server further comprises a comparison program configured to automatically compare the second data entered by the users and an evaluation program configured to automatically distribute the first data correlated to money to the users according to the result of the comparison and according to the correlation.
Patent NZ-563127-A (NZ)
Title: High-resolution tracking of industrial process materials using trace incorporation of luminescent markers
Inventor: BOWN MARK
IPC: G01N21/64
Filed: 2006-05-10
Abstract: A method of marking and tracking an industrial process material comprises selectively incorporating a luminescent marker 1 onto and/or into the industrial process material 7 in a trace amount sufficient to be non-destructively optically detectable in and/or on the industrial process material 7 in situ in the field or on-site and using the marker 1 to track, identify and authenticate the industrial process material 7 for at least one of material control, inventory control, stock control, logistics control, quality control and pollution control. The luminescent marker is a luminescent metal complex or an inorganic phosphor that emits phosphorescence.
Patent NZ-563678-A (NZ)
Title: Synergistic modulation of FLT3 kinase using 4-cyano-1H-imidazole-2-carboxylic acid{2-cyclohex-1-enyl-4-[1-(2-dimethylamino-acetyl)-piperidin-4-yl]-phenyl}amide and a farnesyl transferase inhibitor
Inventor: BAUMANN CHRISTIAN ANDREW
IPC: A61K31/00
Filed: 2006-06-07
Abstract: The depicted FLT3 kinase inhibitor acts synergistically with a farnesyl transferase inhibitor such as tipifarnib or cytarabine to reduce tumour volume or prevent cell proliferative disorders such as acute myeloid leukemia, acute lymphocytic leukemia and myelodysplastic syndrome.
Patent NZ-567256-A (NZ)
Title: Pole with slidable tidal power generator attached under the water and further wave generator attached to pole
Inventor: FRAENKEL PETER LEONARD
IPC: F03B13/14
Filed: 2006-10-18
Abstract: Disclosed is an energy conversion system for obtaining power from a volume of non-static water. The system includes an elongate hollow columnar/monopole support structure (5) upstanding within a volume of water subject to the occurrence of both wave motion and tidal flow. At least one submergible power generation means (1, 2, 3, 4) for deriving power from the tidal flow mounted to a support arrangement (4) is externally mounted upon the columnar support structure and is displaceable lengthways. Wave motion responsive means (20, 21) are mounted to the support structure and are responsive to wave motion (9) to enable the production of power.
Patent NZ-568384-A (NZ)
Title: Therapeutic vaccine comprising Abeta peptide
Inventor: PFEIFER ANDREA
IPC: C07K16/18
Filed: 2006-12-08
Abstract: Disclosed is a method of producing a therapeutic vaccine composition comprising an antigenic construct comprising a modified Abeta antigenic peptide fragment consisting of a single or repetitive stretch of between 13 and 15 contiguous amino acid residues from the N-terminal fragment 1-16 or 1-17 of the Abeta peptide. The Abeta peptide antigen is preformed by on-resin standard automated peptide synthesis and modified by on-resin grafting of a lipophilic or hydrophobic moiety to the terminal amino acid residues of the pre-formed Abeta peptide. Also disclosed is the vaccine made by the method and its use in the treatment of an amyloid associated disease or condition.
Patent NZ-569107-A (NZ)
Title: Extending keyword searching to syntactically and semantically annotated data
Inventor: MARCHISIO GIOVANNI B
IPC: G06F17/30
Filed: 2006-11-16
Abstract: A method for performing relationship searches on a corpus of documents and relationship search navigation tip engine are disclosed. The search navigation tip engine comprises a computer processor; a data repository configured to maintain rules that map between one or more relationship query components and corresponding specifications of relationship queries; a storage medium comprising a tip search manager and a storage medium comprising a tip searcher. The tip search manager, when executed on the computer processor, is configured to parse the rules stored in the data repository to generate mappings between potential input queries and corresponding relationship searches to be executed. Each relationship search indicates one or more terms and associated syntactic and/or semantic information used to convey how the one or more terms are to be understood in relation to the corpus and can include a separate document constraint portion specifying a designated ontology path specification or context operator portion specifying an entity and/or an action. The tip searcher, when executed on the computer processor, is configured to receive an input query, determine, using the tip search manager, a plurality of mappings that correspond to the input query, execute the plurality of different relationship searches that correspond to the determined plurality of mappings to generate corresponding search results, and return indications to the executed relationship searches that generated successful corresponding search results.
Patent NZ-572693-A (NZ)
Title: Autofeed mechanism for heated humidifier chamber
Inventor: RUSTAD ANDRE
IPC: A61M16/16
Filed: 2007-04-16
Abstract: An auto-feed mechanism for controlling the flow and level of a fluid into a humidifier chamber includes a body (100) with an inlet chamber (210) and a float chamber (220). A seat (240) permits fluid communication between the two chambers (210, 220). A float (250) and a ball (230) cooperate to permit, or deny, access to the seat (240). Fluid first enters the inlet (270) and fills the chamber (210) and then enters the float chamber (220) by passing through the seat (240) and exiting via the exit (280). Initially, the weight of the float (250) keeps the ball (230) away from the seat (240), but eventually the fluid level rises high enough that the action of the float (250) on the ball (230) decreases to a level that is overcome by the buoyant force of the ball (230) and other fluidic forces resulting in the ball (230) moving away from the ball support (214). Finally, the ball (230) rises enough to seal against the seat (240) thus stopping the flow of fluid.
Patent NZ-573248-A (NZ)
Title: Use of allopurinol (1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one) for the treatment of palmar plantar erythrodysesthesia
Inventor: RODEMER YOLANDA
IPC: A61K31/4162
Filed: 2007-05-31
Abstract: Disclosed is the use of allopurinol (1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one) or a pharmaceutically acceptable salt thereof in the manufacture of a medicament for the treatment or prevention of palmar plantar erythrodysesthesia (PPE) induced by fluoropyrimidine chemotherapy. Also disclosed is a pharmaceutical composition for the topical administration to the skin, comprising from 1-10 % by weight of the total composition of allopurinol or a pharmaceutically acceptable salt thereof, with the proviso that it does not comprise methylsulphonylmethane or cetomacrogol (a polyethylene glycol surfactant).
Patent NZ-576621-A (NZ)
Title: Air cooling jet pump system for a combustion powered piston device
Inventor: ADAMS JOSEPH S
IPC: B25C1/08
Filed: 2007-11-12
Abstract: Disclosed is a cooling system (10) for combustion-powered fastener-driving tools. The system comprises the use of cooling fin structures (36, 38) upon the external wall members of the combustion chamber (14) and cylinder (16). Fluid flow paths are constructed between internal wall portions of a surrounding tool housing (26) and the cooling fin structures mounted upon the external wall members of the combustion chamber and cylinder. In this manner, ambient cooling air is passed over and through the cooling fin structures whereby the combustion chamber and cylinder components of the fastener-driving tool are efficiently cooled such that the temperature level of the fastener-driving tool is maintained at a desirable temperature level despite the substantial amount of heat normally generated during each combustion cycle.
Patent NZ-576636-A (NZ)
Title: A method for screening for a substance having an action of proliferating natural killer cells
Inventor: KUHARA TETSUYA
IPC: A61K31/787
Filed: 2005-09-07
Abstract: Provided is a method for screening for a substance having an action of proliferating natural killer (NK) cells in a living body of a non-human animal, which comprises: administering a test substance every day for 7 days to the non-human animal and administering polyinosinic-polycytidylic acid once on day 5, counting from starting dose of the test substance, thereby enhancing an action of the test substance for proliferating NK cells; detecting the action of proliferating NK cells in the non-human animal based on an action of enhancing or activating a natural killer activity; and selecting a test substance capable of proliferating NK cells. (62) Divided Out of 546174
Patent NZ-580195-A (NZ)
Title: Targeting crac for breast cancer therapy and/or diagnosis
Inventor: MONTEITH GREGORY RAYMOND
IPC: A61K33/244
Filed: 2008-03-05
Abstract: Disclosed are methods for identifying therapeutics and diagnosis. In general, methods for identifying therapeutic agents directed to calcium flow are disclosed. Also provided are methods for diagnosis of breast cancer and/or a predisposition to breast cancer and methods of treatment of breast cancer. The methods include identifying therapeutic agents which modulate a CRAC channel and/or a glycoprotein activator of a CRAC channel. Also provided are diagnostic methods that ultilise a CRAC channel and/or a glycoprotein activator of a CRAC channel.
Patent NZ-583336-A (NZ)
Title: Synergistic mixtures of anthranilamide invertebrate pest control agents with sodium channel modulators
Inventor: ANNAN ISAAC BILLY
IPC: A01N43/56
Filed: 2005-06-30
Abstract: Disclosed is a method for controlling an invertebrate pest selected from the list given in the specification comprising contacting the pest or its environment with a mixture comprising: (a) a compound of Formula 1, which 3-bromo-N-[4-chloro-2-methyl-6- [(methylamino)carbonyl]phenyl]-1-(3-chloro-2-pyridinyl)-lH-pyrazole-5-carboxamide, or an an N-oxide or salt thereof, and (b) either deltamethrin and lambda-cyhalothrin or a salt thereof, where the ratios of the components is given in the specification. (62) Divided Out of 551814
Patent NZ-583806-A (NZ)
Title: Displaying data from an ultrasound scanning device containing position and orientation sensors
Inventor: MEDLIN ANDREW JOHN
IPC: G01S15/02
Filed: 2008-08-29
Abstract: Disclosed is a method for forming an image of a target from echo return data in an ultrasound system. The method is performed by first moving a probe unit containing an ultrasound transducer over a body to be imaged and receiving echo return data from the ultrasound transducer. This data is combined with output data from a sensor adapted to provide information about the position and/or orientation of the probe unit to produce a series of scanlines (81). These scanlines (81) each include echo intensity data and information defining the position and/or orientation of the scanline (81). A transform is then calculated and applied to the scanlines (81) to map the scanlines (81) to a plane of best fit. This transformed data is then mapped to a raster image formed by displaying an array of pixel (84) buffer brightness values. These values are produced by determining a first set of intersection points (83) between a centreline (82) of a first pixel row and each scanline (81) and determining a second set of intersection points for a second pixel row adjacent to the first pixel row from the first set of intersection points. Subsequently, the value of the data point on each scanline (81) which is nearest to each intersection (83) is assigned to be the pixel (84) buffer brightness value. Where such assignment would result in more than one brightness value for a particular pixel (84), the average of these values is assigned as the pixel (84) buffer brightness value.
Patent NZ-585086-A (NZ)
Title: Tetrahydroquinoline derivatives for treating post-traumatic stress disorders
Inventor: JENCK FRANCOIS
IPC: A61K31/4725
Filed: 2008-10-09
Abstract: Disclosed are tetrahydroquinoline compounds of formula Ia or a pharmaceutically acceptable salt, for treating a post-traumatic stress disorder. A Specific example of a compound of formula Ia is (R)-2-{ (S)-6,7-dimethoxy-1-[2-(4-trifluoromethyl-phenyl)-ethyl]-3,4-dihydro-1H-isoquinolin-2-yl)-N-methyl-2-phenyl-acetamide or one of its pharmaceutically acceptable salts.
Patent NZ-586453-A (NZ)
Title: 19-NOR-STEROID DERIVATIVES WITH A 15alpha,16alpha-METHYLENE GROUP AND A SATURATED 17,17-SPIROLACTONE RING, USE THEREOF, AND MEDICAMENTS CONTAINING SAID DERIVATIVES
Inventor: KLAR ULRICH
IPC: C07J53/00
Filed: 2008-12-23
Abstract: Disclosed are 15alpha, 16alpha-methylene-17-hydroxy-19-nor -17-pregna-4-en-3-one-21-carboxylic acid gamma-lactone derivatives of general formula 1 namely, 17-beta-Hydroxy-15alpha, 16alpha-methylene-19-nor-17 alpha-pregna-4-en-3-one-21-carboxylic acid gamma-Iactone, 17beta-Hydroxy-7 alpha-methyl-15alpha, 16alpha-methylene-19-nor-17 alpha-pregna-4-en-3-one-21-carboxylic acid gamma-Iactone, 17beta-Hydroxy-7beta-methyl-15alpha, 16alpha-methylene-19-nor-17 alpha-pregna-4-en-3-one-21-carboxylic acid gamma-Iactone for menopausal complaints and contraception.
Patent NZ-590167-A (NZ)
Title: Conversion of vegetable oils to base oils and transportation fuels
Inventor: MILLER STEPHEN J
IPC: C10G3/00
Filed: 2009-07-22
Abstract: Disclosed is a method for producing a diesel fuel and base oil from vegetable oil comprising the steps of a) providing a triglyceride-containing vegetable oil comprising both saturated and unsaturated fatty acid components; b) processing the triglyceride-containing vegetable oil to effect oligomerization of unsaturated fatty acid components contained therein so as to provide for an oligomerized mixture comprising an oligomer component; c) isomerizing the oligomerized mixture over an isomerization catalyst to yield an isomerized mixture, wherein the isomerized mixture comprises (i) a base oil component derived from oligomerization of the unsaturated fatty acid component, and (i) a diesel fuel component derived from the saturated fatty acid component; d) stripping the isomerized mixture of water to yield a dry isomerized mixture, wherein the dry isomerized mixture comprises at least 10 wt. per cent oligomers as alkanes having a carbon number of 30 or greater and having been derived from the oligomerization of the unsaturated fatty acid component; e) separating the dry isomerized mixture into a lower boiling fraction from which diesel fuel is subsequently derived, and a higher boiling fraction; and f) subsequently further isomerizing at least a portion of the higher boiling fraction to yield a base oil. Also disclosed is a system for producing a base oil or vegetable oil and a diesel fuel or base oil produced by the process.
Patent NZ-595304-A (NZ)
Title: A Humidifier for a respiratory apparatus with a controller configured to control the duty ratio of a heating element
Inventor: SMITH IAN MALCOLM
IPC: A61M16/16
Filed: 2009-03-05
Abstract: 595304 Disclosed is a humidifier for a respiratory apparatus for delivering a humidified flow of breathable gas to a patient. The humidifier has a humidifier chamber configured to store a supply of water to humidify the flow of breathable gas. The humidifier chamber has a first heating element configured to heat the supply of water. The humidifier includes a sensor to detect a humidity of the humidified flow and generate signals indicative of the humidity and a controller configured to receive the signals from the sensor and control the first heating element to provide a predetermined absolute humidity, a predetermined temperature, and/or a predetermined relative humidity to the flow of breathable gas. The controller is configured to control a duty ratio of the first heating element.
Patent NZ-595912-A (NZ)
Title: Film for production of composite material artefacts, production method of said film and production method of composite material artefacts using said film
Inventor: PERUZZA PAOLO
IPC: B29C70/32
Filed: 2010-03-23
Abstract: 595912 A resin constraint film (1) to be used in production of tubular fibre and resin composite material artefacts (2) which permits to realize, coloured surfaces having colours with intensity, brightness, shine and/or metal look comparable to those that may be obtained by directly spray or brush painting the composite-material artefact at the end of the polymerization process of the thermosetting resin. The constraint film (1) is formed with a supporting film (6) made of biaxially oriented polypropylene, by an intermediate layer (7) of release chemical product that coats the front face (6a) of the supporting film (6) intended to come into contact with the semi-finished product (2’) which will give rise to the composite material artefact (2), and by a surface layer (8) of metal coating material applied onto the intermediate layer (7) via vacuum vaporisation deposition.
Patent NZ-597621-A (NZ)
Title: Sustained delivery formulations of risperidone compounds
Inventor: DADEY ERIC
IPC: A61K31/423
Filed: 2008-02-13
Abstract: 597621 Disclosed is the use of a flowable composition comprising: (i) a biodegradable thermoplastic polymer that is a polyester of one or more hydroxycarboxylic acids, or is a polyester of a combination of one or more diols and one or more dicarboxylic acids; (ii) a biocompatible polar aprotic organic liquid selected from the group consisting of an amide, an ester, a carbonate, a ketone, an ether, a sulfonyl, and any combination thereof; and (iii) an effective amount of risperidone, 9-hydroxyrisperidone or a pharmaceutically acceptable organic or inorganic salt thereof; in the manufacture of a medicament for the treatment of medical condition selected from the group consisting of delusional psychosis, schizophrenia, bipolar disorder, psychotic depression, obsessive compulsion disorder, Tourette syndrome, autistic spectrum disorders, and any combination thereof; wherein the medicament is adapted to be injected into a patient and further wherein the medicament is formulated to form a solid microporous biodegradable implant under physiological conditions; and wherein the implant releases the effective amount of the risperidone, 9-hydroxyrisperidone or pharmaceutically acceptable organic or inorganic salt thereof by diffusion, erosion, or a combination of diffusion and erosion as the implant biodegrades in the patient.